0002014303-24-000002.txt : 20240709 0002014303-24-000002.hdr.sgml : 20240709 20240708183807 ACCESSION NUMBER: 0002014303-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20240709 DATE AS OF CHANGE: 20240708 EFFECTIVENESS DATE: 20240709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FR-0226 Fund II, a series of Psychedelic Medicine SPV, LP CENTRAL INDEX KEY: 0002014303 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-518026 FILM NUMBER: 241106036 BUSINESS ADDRESS: STREET 1: 119 SOUTH MAIN STREET STREET 2: SUITE 220 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 2068016359 MAIL ADDRESS: STREET 1: 119 SOUTH MAIN STREET STREET 2: SUITE 220 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0002014303 FR-0226 Fund II, a series of Psychedelic Medicine SPV, LP 119 SOUTH MAIN STREET SUITE 220 SEATTLE WA WASHINGTON 98104 2068016359 DELAWARE None None Limited Partnership true 2024 LLC Fund GP, PO Box 3217 Seattle WA WASHINGTON 98114 Director General partner of the Issuer Ltd. Belltower Fund Group, 119 South Main St, Suite 220 Seattle WA WASHINGTON 98104 Director Agent of the general partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2024-06-14 false true false 500 111000 111000 0 false 16 0 0 7000 true This amount represents the dollar value of a one-time fee and an annual fee paid to the fund administrator and/or its affiliates to cover administrative expenses for the life of the fund. false FR-0226 Fund II, a series of Psychedelic Medicine SPV, LP /s/ Abraham Wilson Abraham Wilson Authorized Officer of the Agent of Issuer's GP 2024-07-08